However, the lack of a complete blood biochemistry analysis in many studies limits the ability to distinguish whether OPN elevations are specific to cardiovascular damage or influenced by comorbid conditions, such as diabetes, renal dysfunction, or systemic inflammatory diseases. This evidence concerns the gene SPP1 and diabetes mellitus.